Showing results (1261-1270 of 2,166) with videos related to

Sort By:
Pageof 217
Journal of Interventional Cardiology|November 21, 2008
A Bayesian meta-analysis comparing AngioJet thrombectomy to percutaneous coronary intervention alone in acute myocardial infarctionCindy L Grines, Teresa R Nelson, Robert D Safian, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2023
Genomic and geographical structure of human cytomegalovirusOscar J Charles, Cristina Venturini, Soren Gantt, et al.
The Annals of Pharmacotherapy|June 17, 2016
Clinical Utility of Routine Cardiac Monitoring in Breast Cancer Patients Receiving TrastuzumabChristine C Davis, Amelia Zelnak, J William Eley, et al.
Circulation. Heart Failure|May 23, 2012
Electrocardiographic characteristics of potential organ donors and associations with cardiac allograft useKiran K Khush, Rebecca Menza, John Nguyen, et al.
Ocular Immunology and Inflammation|August 14, 2018
The Influence of Race and Sex on the Side Effect Profile of Methotrexate in the Treatment of UveitisKara C LaMattina, Sarah M Escott, Julia F Malalis, et al.
Journal of the American College of Cardiology|May 1, 1991
Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imagingR M Fleming, R L Kirkeeide, H Taegtmeyer, et al.
The American Journal of Cardiology|June 30, 1998
Determination of pretest probability for detection of a cardiovascular source of emboli by transesophageal echocardiography using clinical and transthoracic echocardiographic dataA Shiran, S A Goldstein, S Zafar, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2025
Benchmarking pathology foundation models for non-neoplastic pathology in the placentaZehao Peng, Marina A Ayad, Yaxing Jing, et al.
British Journal of Cancer|August 4, 2023
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategiesAustin Wesevich, Daniel A Goldstein, Koosha Paydary, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 13, 2006
A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression systemSu-Jun Lee, Ilse P van der Heiden, Joyce A Goldstein, et al.
Pageof 217